Page last updated: 2024-08-16

timolol and Kaposi Sarcoma

timolol has been researched along with Kaposi Sarcoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (54.55)24.3611
2020's5 (45.45)2.80

Authors

AuthorsStudies
de la Cruz, E; Galván, C; Lozano-Masdemont, B; Marinero, S; Pérez-Tato, B; Polimón, I1
Alfano, R; Argenziano, G; Babino, G; Briatico, G; Fulgione, E; Gambardella, A; Giorgio, CMR; Licata, G1
Brambilla, L; Maronese, CA; Tourlaki, A1
Ambrogio, F; Bonamonte, D; De Marco, A; Filoni, A; Pacifico, A1
Fernández-Redondo, V; Pousa-Martínez, M; Sainz-Gaspar, L; Suárez-Peñaranda, JM; Vázquez-Veiga, H1
Braue, A; Chap, S; Robinson, AJ; Scardamaglia, L; Varigos, GA; Vu, M1
Abdelmaksoud, A; Filoni, A; Giudice, G; Vestita, M2
Cuenca-Barrales, C; Espadafor-López, B; Ruiz-Villaverde, R; Salvador-Rodriguez, L1
Bordel-Gómez, MT; Cardeñoso-Álvarez, ME; Fraile-Alonso, MC; Meseguer-Yebra, C; Pérez-Losada, ME; Sánchez-Estella, J1
Alcántara-Reifs, CM; Garnacho-Saucedo, GM; Salido-Vallejo, R; Vélez García-Nieto, A1

Reviews

1 review(s) available for timolol and Kaposi Sarcoma

ArticleYear
Topical beta-blockers in dermatologic therapy.
    Dermatologic therapy, 2021, Volume: 34, Issue:4

    Topics: Adrenergic beta-Antagonists; Granuloma, Pyogenic; Humans; Sarcoma, Kaposi; Skin Diseases; Timolol

2021

Other Studies

10 other study(ies) available for timolol and Kaposi Sarcoma

ArticleYear
Allergic contact dermatitis caused by timolol eyedrop application for classic Kaposi sarcoma.
    The Australasian journal of dermatology, 2020, Volume: 61, Issue:4

    Topics: Administration, Topical; Aged; Dermatitis, Allergic Contact; Humans; Male; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2020
Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.
    International journal of dermatology, 2021, Volume: 60, Issue:5

    Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2021
Successful treatment of conjunctival classic Kaposi's sarcoma with topical timolol.
    Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:5

    Topics: Conjunctiva; Conjunctival Neoplasms; Humans; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2021
Topical timolol for treatment of penile Kaposi sarcoma in HIV-negative patient.
    Dermatologic therapy, 2017, Volume: 30, Issue:5

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Humans; Male; Penile Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome

2017
Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.
    The Australasian journal of dermatology, 2017, Volume: 58, Issue:3

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Humans; Iatrogenic Disease; Leg; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome

2017
Topical timolol for Kaposi sarcoma: An innovation.
    The Australasian journal of dermatology, 2018, Volume: 59, Issue:4

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Humans; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2018
Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol.
    Actas dermo-sifiliograficas, 2020, Volume: 111, Issue:2

    Topics: Administration, Topical; Aged; Female; Humans; Iatrogenic Disease; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2020
Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases.
    The British journal of dermatology, 2015, Volume: 173, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Foot Diseases; Humans; Leg; Male; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome

2015
Classic Kaposi's sarcoma treated with topical 0.5% timolol gel.
    Dermatologic therapy, 2016, Volume: 29, Issue:5

    Topics: Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Gels; Humans; Male; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome; Ultrasonography, Doppler, Color

2016
Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.
    Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Antiretroviral Therapy, Highly Active; Female; Gels; HIV Infections; Humans; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Timolol

2017